All In Biotech

Drug Trial Radar · NCT05197049

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

CNTO1959CRD3004: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

350

Actual

Start

Jan 19, 2022

Primary completion

Jul 4, 2023

Study completion Mar 27, 2028

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jan 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Conditions

  • Crohn Disease

Interventions

  • Guselkumab Dose 1Drug

    Guselkumab (Dose 1) will be administered by subcutaneous (SC) injection.

  • Guselkumab Dose 2Drug

    Guselkumab (Dose 2) will be administered by SC injection.

  • Guselkumab Dose 3Drug

    Guselkumab (Dose 3) will be administered by SC injection.

  • PlaceboDrug

    Placebo will be administered by SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved Clinical Remission at Week 12Time frame: At Week 12
  2. Percentage of Participants Who Achieved Endoscopic Response at Week 12Time frame: At Week 12

Locations

345 sites in 27 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists of the Southeast

    Dothan, Alabama

  • Advanced Gastro P.C

    Chandler, Arizona

  • Reliance Research

    Scottsdale, Arizona

  • Moore Clinical Trials, LLC

    Little Rock, Arkansas

  • Central Arkansas Veterans Healthcare System

    Little Rock, Arkansas

  • Clinnova Research

    Anaheim, California

  • Om Research LLC 1

    Lancaster, California

  • Om Research LLC

    Lancaster, California

  • United Gastroenterologists

    Los Alamitos, California

  • Paul Wallace MD

    Los Angeles, California

  • Digestive System Healthcare

    Pasadena, California

  • Northshore Gastroenterology Research, LLC

    San Diego, California

  • Clinical Applications Laboratories, Inc

    San Diego, California

  • Santa Maria Gastroenterology

    Santa Maria, California

  • Clinical Research of California

    Walnut Creek, California

  • Amel Med LLC Research

    Grand Junction, Colorado

  • Western Connecticut Health Network/Danbury Hospital

    Danbury, Connecticut

  • Gastroenterology Associates of SW Florida

    Clearwater, Florida

  • Pioneer Research Solutions Inc.

    Coconut Creek, Florida

  • Omega Research Consultants

    DeBary, Florida

  • Harmony Medical Research Institute, Inc.

    Hialeah, Florida

  • Central Florida Gastro Research

    Kissimmee, Florida

  • Community Research Foundation, Inc.

    Miami, Florida

  • Gastroenterology Group Of Naples

    Naples, Florida

  • Center for Digestive Health

    Orlando, Florida

  • Central Florida Internists

    Orlando, Florida

  • Synergy Clinical Research

    St. Petersburg, Florida

  • Atlanta Gastroenterology Specialists, PC

    Atlanta, Georgia

  • Agile Clinical Research Trials, LLC

    Atlanta, Georgia

  • Atlanta Center For Gastroenterology

    Decatur, Georgia

  • Gastroenterolgy Associates of Central GA

    Macon, Georgia

  • Gastroenterology Consultants

    Roswell, Georgia

  • USF Asthma, Allergy, Immunology Clinical Research Unit

    Boise, Idaho

  • Grand Teton Research Group, PLLC

    Idaho Falls, Idaho

  • Lemah Creek Clinical Research

    Oakbrook Terrace, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • BVL Clinical Research

    Leawood, Kansas

  • Cotton O'Neil Digestive Health Center

    Topeka, Kansas

  • Tri-State Gastroenterology Assoc

    Crestview Hills, Kentucky

  • Tandem Clinical Research

    Marrero, Louisiana

Showing 40 of 345 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.